::: Sanofi-Aventis EPS growth in Q2 2010
first-half net sales, second-quarter net sales, business net income statement, sales growth figures, reconciliation of business net income, Business net income1, constant exchange rates1, Vaccines sales, Exchange rate movements, Sanofi-Aventis EPS growth

::: Merrion Pharmaceuticals new facility is granted license to manufacture by Irish Medicines Board
Merrion Pharmaceuticals new facility, Merrion Pharmaceuticals plc, CEO Merrion Pharmaceuticals, new drug products, new oral drugs, Citywest facility, clinical development, oral GIPET formulations of their products, proprietary drugs using GIPET, sq.ft facility

::: Diamyd Receives USD 45 Million Upfront Payment
CEO Diamyd Medical AB, GAD-based drug Diamyd, President of Diamyd Medical, Swedish diabetes company focusing, Johnson company, upfront payment of USD, development program, additional development, development of pharmaceuticals, Swedish Securities Markets Act

::: CT Atlantic AG Announces Appointment of Michael Höcker to CEO
CT Atlantic AG, Cara Lerner, Chairman of the Board of CT Atlantic, management experience, experienced pharmaceutical program, management of technology development programs, pharmaceutical executive, Head of Program Management, Project Management, biotechnology company aiming

::: Trophos publishes the identification and characterization of the novel cardioprotective compound, TRO40303
mitochondrial permeability transition pore, latest Trophos mitochondrial pore modulator, role of mitochondrial permeability transition, TRO40303 binds, heart tissue following MI, Cardiac reperfusion injury, clinical development, MI patients